RE:RE:RE:RE:RE:RE:Biotech buyouts.
to Noteable, let me preface this by saying I do like reading your posts. Chacun a son gout.
Yes. Not in a buyout. But their best foot forward is we want at least Canada, and that want complicates matters. Perhaps this is done in biotech; surely Pharma knows how to handle this sort of thing. They should just pass it on.
You did remind me of something I had been thinking about a while back. That is AN. They have broad rights to pelareorep. Perhaps they have a buyer for those rights. Not sure if they could just sell the rights. I do imagine if they got bought out the rights would go with. Cheers
PS Does MC have rights that would be akin to an NSR in mining? TIA